Jin Guan-Nan, Zou Ping, Chen Wan-Xin, Ding Ze-Yang, Zhou Hao
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China.
Diagn Cytopathol. 2013 Mar;41(3):253-6. doi: 10.1002/dc.21795. Epub 2011 Aug 26.
The t(9;22)(q34;q11) translocation between bcr and abl genes plays a pivotal role in the pathogenesis and diagnosis of chronic myelogenous leukemia (CML). Fluorescence in situ hybridization (FISH) using specific DNA probes provides a useful and accurate way for the detection of bcr/abl fusion gene in single cell. Here, we report an unusual case of a patient with no prior hematologic disease who initially manifested lymphadenopathy. The lymph node findings were suspicious for T-lineage lymphoblastic lymphoma, however, his blood and bone marrow at that time were in chronic phase of CML. This presented difficulty for accurate discrimination between CML blast crisis (BC) and non-Hodgkin's lymphomas (NHLs). To discern where the extramedullary nodal malignancy originated from, we cytologically analyzed lymph node biopsies and bone marrow with FISH to detect bcr/abl fusion signals. Together with the morphology, immunohistochemistry, cytogenetics as well as molecular analysis, the patient was diagnosed as extramedullary T-lymphoid BC of Ph+ CML. In conclusion, this case is unusual at three levels: first, extramedullary nodal BC as a presenting manifestation of CML is rare and the blasts are of precursor T lymphoblastic lineage, rather than the more common B-cell lineage; second, this case suggests that extramedullary lymphoid nodal BC of CML can exist independently without the bone marrow developing into BC; and third, FISH analysis on the single neoplastic cell is an accurate way to confirm that the neoplasm is either extramedullary localized blasts of CML or genetically distinct neoplasm.
bcr基因与abl基因之间的t(9;22)(q34;q11)易位在慢性粒细胞白血病(CML)的发病机制和诊断中起着关键作用。使用特异性DNA探针的荧光原位杂交(FISH)为单细胞中bcr/abl融合基因的检测提供了一种有用且准确的方法。在此,我们报告一例非同寻常的病例,患者既往无血液系统疾病,最初表现为淋巴结病。淋巴结检查结果怀疑为T系淋巴细胞淋巴瘤,然而,当时他的血液和骨髓处于CML慢性期。这给准确区分CML急变期(BC)和非霍奇金淋巴瘤(NHL)带来了困难。为了辨别髓外淋巴结恶性肿瘤的起源,我们对淋巴结活检组织和骨髓进行了细胞学分析,并采用FISH检测bcr/abl融合信号。结合形态学、免疫组织化学、细胞遗传学以及分子分析,该患者被诊断为Ph+ CML的髓外T淋巴细胞急变期。总之,该病例在三个层面上非同寻常:第一,作为CML的首发表现,髓外淋巴结急变期罕见,且原始细胞为前体T淋巴细胞系,而非更常见的B细胞系;第二,该病例提示CML的髓外淋巴结急变期可独立存在,而骨髓未发展为急变期;第三,对单个肿瘤细胞进行FISH分析是确认肿瘤是CML的髓外局限性原始细胞还是基因上不同的肿瘤的准确方法。